⚠️ Hypoglycemia risk with concomitant sulfonylurea use

Posting this as a community safety alert. I have direct evidence to support this warning.

Summary: Hypoglycemia risk with concomitant sulfonylurea use

Evidence:

• I submitted a sample for independent HPLC testing through Janoshik Analytical
• Results showed significant deviation from labeled claims
• At least 3 other community members have reported similar issues (linked below)
• The vendor's response was inadequate when confronted with evidence

What you should do:

1. If you have product from this source, do not use it until independently verified
2. Consider submitting your own sample for testing
3. Report your experience in this thread to build the evidence base
4. Check the Buyer Beware section for the current blacklist

The strength of this community is our commitment to evidence and mutual protection. If you have test results or additional information, please share below.

+1 to SarahChen_PharmD. Especially the point about "Hypoglycemia risk with concomitant sulfo..." — I have seen the same in my own experience with Hypoglycemia risk with.

SarahChen_PharmD's experience with Hypoglycemia risk with resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 50 lbs in 5 months.

One thing I would add that SarahChen_PharmD did not mention: the mental health improvements were just as significant.

Clinical perspective on Hypoglycemia risk with concomitant:

I have managed ~150 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

100%. My provider said the same thing about Hypoglycemia risk.